The isolation of enzymes with tailored physical and catalytic properties is one of the fundamental thrusts of modern protein science, with the potential for profound societal, technological, and medical impact. The broad, long term objective of the proposed research is to develop the experimental framework that will define the scientific and technological foundation for evolutionary design of precisely specific and highly active new enzyme catalysts. Recent technological breakthroughs in our laboratory make possible the first ultra-high throughput analyses and selections of enzyme function in large libraries, based on expression on the surface of E. coli bacteria and sorting/analysis by high speed, multi-color flow cytometry. A key feature of our new approach is the ability to select for (and quantify) desired new activity, while simultaneously deselecting (and quantifying) unwanted catalytic activity. This new technology will be exploited to investigate, in a systematic manner, the key experimental parameters of mutation rate and mutation method during the evolution of the two most important aspects of enzyme catalysis; substrate specificity and catalytic chemistry. In particular, we will be evolving new specificity and catalytic chemistry in two complementary enzyme systems, the bacterial serine protease OmpT, a representative """"""""specialist"""""""" enzyme, (an enzyme with precise substrate specificity), and P. solani cutinase, a member of the a/13 hydrolase superfamily that is a """"""""generalist"""""""" enzyme (one that exhibits broad esterolytic reactivity with various substrates). The bottom line is that following the proposed studies, we will, for the first time, have enough systematic data to provide calibration with respect to what changes in substrate specificity and catalytic chemistry are feasible using enzyme directed evolution, and what approaches to enzyme randomization and substrate selection bring about maximum beneficial changes of function.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM065551-04
Application #
7086771
Study Section
Special Emphasis Panel (ZRG1-SSS-B (01))
Program Officer
Jones, Warren
Project Start
2003-07-01
Project End
2008-11-30
Budget Start
2006-07-01
Budget End
2008-11-30
Support Year
4
Fiscal Year
2006
Total Cost
$275,871
Indirect Cost
Name
University of Texas Austin
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
170230239
City
Austin
State
TX
Country
United States
Zip Code
78712
Yi, Li; Gebhard, Mark C; Li, Qing et al. (2013) Engineering of TEV protease variants by yeast ER sequestration screening (YESS) of combinatorial libraries. Proc Natl Acad Sci U S A 110:7229-34
Yoo, Tae Hyeon; Pogson, Mark; Iverson, Brent L et al. (2012) Directed evolution of highly selective proteases by using a novel FACS-based screen that capitalizes on the p53 regulator MDM2. Chembiochem 13:649-53
Cantor, Jason R; Yoo, Tae Hyeon; Dixit, Aakanksha et al. (2011) Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift. Proc Natl Acad Sci U S A 108:1272-7
Chu, Yongjun; Hoffman, David W; Iverson, Brent L (2009) A pseudocatenane structure formed between DNA and A cyclic bisintercalator. J Am Chem Soc 131:3499-508
Pogson, Mark; Georgiou, George; Iverson, Brent L (2009) Engineering next generation proteases. Curr Opin Biotechnol 20:390-7
Varadarajan, Navin; Pogson, Mark; Georgiou, George et al. (2009) Proteases that can distinguish among different post-translational forms of tyrosine engineered using multicolor flow cytometry. J Am Chem Soc 131:18186-90
Varadarajan, Navin; Rodriguez, Sarah; Hwang, Bum-Yeol et al. (2008) Highly active and selective endopeptidases with programmed substrate specificities. Nat Chem Biol 4:290-4
Li, Hai-Xin; Hwang, Bum-Yeol; Laxmikanthan, Gurunathan et al. (2008) Substrate specificity of human kallikreins 1 and 6 determined by phage display. Protein Sci 17:664-72
Varadarajan, Navin; Georgiou, George; Iverson, Brent L (2008) An engineered protease that cleaves specifically after sulfated tyrosine. Angew Chem Int Ed Engl 47:7861-3
Varadarajan, Navin; Gam, Jongsik; Olsen, Mark J et al. (2005) Engineering of protease variants exhibiting high catalytic activity and exquisite substrate selectivity. Proc Natl Acad Sci U S A 102:6855-60

Showing the most recent 10 out of 11 publications